Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung

Jonathan B Volmer1, Linda F Thompson, Michael R Blackburn

  • 1Department of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston, Medical School, Houston, 77030, USA.

Insights

Ecto-5'-nucleotidase (CD73) generates adenosine, reducing inflammation and fibrosis in bleomycin-induced lung injury. Restoring CD73 activity in mice lessened lung damage, highlighting its protective role.

Area of Science:

  • Biochemistry
  • Immunology
  • Pulmonary Medicine

Background:

  • Adenosine signaling plays a critical role in regulating inflammation and tissue injury.
  • Mechanisms of adenosine production during tissue injury are not fully understood.
  • Adenosine levels increase rapidly following tissue damage.

Purpose of the Study:

  • To investigate the role of ecto-5 omino-nucleotidase (CD73) in adenosine production during bleomycin-induced lung injury.
  • To determine the contribution of CD73 to pulmonary inflammation and fibrosis.
  • To assess the therapeutic potential of CD73-dependent adenosine production.

Main Methods:

  • Bleomycin-induced lung injury model in wild-type and CD73 knockout mice.
  • Measurement of adenosine levels and CD73 activity in lung tissue.
  • Assessment of pulmonary inflammation and fibrosis markers.
  • Treatment with exogenous nucleotidase in vivo.

Main Results:

  • Bleomycin challenge elevated adenosine levels and CD73 activity in mouse lungs.
  • CD73 knockout mice showed impaired adenosine accumulation and exacerbated lung inflammation and fibrosis.
  • Exogenous nucleotidase administration restored adenosine levels and reduced lung injury in CD73 knockout mice.
  • Supplementation with exogenous nucleotidase also reduced inflammation in wild-type mice.

Conclusions:

  • CD73-dependent adenosine production is a primary mechanism for generating adenosine in bleomycin-induced lung injury.
  • CD73 plays a protective role by mitigating pulmonary inflammation and fibrosis.
  • Targeting CD73-mediated adenosine production represents a potential therapeutic strategy for lung injury.

Related Concept Videos